OTTAWA, ON — Canadians look to the 44th Parliament to apply lessons learned from COVID-19 to protect current and future generations. This includes building healthcare systems equipped for both exceptional… Read More
BURNABY, BC – Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a clinical stage biopharmaceutical company, today announced that it has commenced an underwritten public offering of $250 million of its common shares… Read More
MISSISSAUGA, ONT – GSK today announced it has signed an agreement with the Government of Canada to supply 10,000 doses of Sotrovimab for injection, a COVID-19 monoclonal antibody therapy developed… Read More
VANCOUVER BC – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the manufacturing and clinical development of rare cannabinoids, today announced that it has commenced its… Read More
Bold Therapeutics is pleased to be featured in Insights Magazine’s Fall Issue. The article: “Bold Therapeutics: Defeating Cancer Drug Resistance” highlights the incredible work we are doing in oncology, including our… Read More
